112 related articles for article (PubMed ID: 16968722)
1. Effect of peritoneal dialysis on renal morphology and function.
Breborowicz A; Pawlaczyk K; Polubinska A; Górna K; Wieslander A; Carlsson O; Tam P; Wu G
Nephrol Dial Transplant; 2006 Dec; 21(12):3539-44. PubMed ID: 16968722
[TBL] [Abstract][Full Text] [Related]
2. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats.
Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
Nephrol Dial Transplant; 2005 Jan; 20(1):189-93. PubMed ID: 15572385
[TBL] [Abstract][Full Text] [Related]
4. Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure.
Müller-Krebs S; Kihm LP; Zeier B; Gross ML; Deppisch R; Wieslander A; Henle T; Penndorf I; Oh J; Reiser J; Nawroth PP; Zeier M; Schwenger V
Eur J Clin Invest; 2008 May; 38(5):296-305. PubMed ID: 18346151
[TBL] [Abstract][Full Text] [Related]
5. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
[TBL] [Abstract][Full Text] [Related]
6. Influence of peritoneal dialysis on the progression of chronic renal failure.
Wang T; Ye RG; Zhen ZH; Li HQ; Mai WY
Adv Perit Dial; 1995; 11():139-41. PubMed ID: 8534688
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of furosemide in patients on peritoneal dialysis.
Flinn A; Ledger S; Blake P
CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
[TBL] [Abstract][Full Text] [Related]
8. Effect of iodinated contrast agents on residual renal function in PD patients.
Moranne O; Willoteaux S; Pagniez D; Dequiedt P; Boulanger E
Nephrol Dial Transplant; 2006 Apr; 21(4):1040-5. PubMed ID: 16352623
[TBL] [Abstract][Full Text] [Related]
9. Iron sucrose induced morphological and functional changes in the rat kidney.
Breborowicz A; Polubinska A; Górna K; Breborowicz M; Oreopoulos DG
Transl Res; 2006 Nov; 148(5):257-62. PubMed ID: 17145571
[TBL] [Abstract][Full Text] [Related]
10. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
11. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
Song J; Meng L; Li S; Qu L; Li X
Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
[TBL] [Abstract][Full Text] [Related]
12. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
Kim S; Oh J; Kim S; Chung W; Ahn C; Kim SG; Oh KH
Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
[TBL] [Abstract][Full Text] [Related]
13. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
[TBL] [Abstract][Full Text] [Related]
14. Glucose and mannitol have different effects on peritoneal morphology in chronically dialyzed rats.
Styszynski A; Kwiatkowska B; Wieczorowska-Tobis K; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2003; 19():15-9. PubMed ID: 14763027
[TBL] [Abstract][Full Text] [Related]
15. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
[TBL] [Abstract][Full Text] [Related]
16. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
17. [Changes in renal function in patients with severe hepatitis and liver cancer with cirrhosis during orthotopic liver transplantation].
Li XY; Hei ZQ; Li SR; Shen N
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):386-9. PubMed ID: 17631701
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression.
Zheng M; Ye S; Zhai Z; Chen Y; Li X; Yang G; Fan A; Wang Y
J Diabetes Complications; 2009; 23(2):124-9. PubMed ID: 18413206
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20. N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats.
Breborowicz A; Połubinska A; Wu G; Tam P; Oreopoulos DG
Blood Purif; 2006; 24(3):274-81. PubMed ID: 16465047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
